Ellsworth Advisors »

Cytokinetics shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $839k 13k 65.91

More positions owned by Ellsworth Advisors

Spdr Gold Tr Gold Shs (GLD)
Harbor Etf Trust Harbor Commodity (HGER)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded First Tr Enh New (FTSM)
Johnson & Johnson (JNJ)
Apple (AAPL)
Amgen (AMGN)
Enterprise Products Partners (EPD)
Chevron Corporation (CVX)
Alphabet Cap Stk Cl C (GOOG)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Vertiv Holdings Com Cl A (VRT)
Eli Lilly & Co. (LLY)
Altria (MO)
Pepsi (PEP)

View all positions for Ellsworth Advisors

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
UBS Group

View all funds holding Cytokinetics